EIDOS THERAPEUTICS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
EIDOS THERAPEUTICS, INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$81.85 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2020-10-29
- EIDOS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-09-30 was -$30.18M, a 535.38% decline year-over-year.
- EIDOS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-06-30 was -$28.85M.
- EIDOS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-03-31 was -$22.82M.
- EIDOS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was -$18.98M.
- EIDOS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$37.84M.
- EIDOS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was -$40.73M.
- EIDOS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2017 was -$11.94M.
- EIDOS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2016 was -$2.54M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$30.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$59.02M derived: sum of 2 quarters · filed 2020-10-29 | -$81.85M 10-Q · filed 2020-10-29 | -$100.83M derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-06-30 | -$28.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$51.67M 10-Q · filed 2020-08-06 | -$70.65M derived: sum of 3 quarters · filed 2020-08-06 | -$63.72M derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-03-31 | -$22.82M 10-Q · filed 2020-05-08 | -$41.80M derived: sum of 2 quarters · filed 2020-05-08 | -$34.87M derived: sum of 3 quarters · filed 2020-10-29 | -$48.93M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-12-31 | -$18.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$12.05M derived: sum of 2 quarters · filed 2020-10-29 | -$26.10M derived: sum of 3 quarters · filed 2020-10-29 | -$37.84M 10-K · filed 2020-02-26 |
| 2019-09-30 | $6.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$7.12M derived: sum of 2 quarters · filed 2020-10-29 | -$18.86M 10-Q · filed 2020-10-29 | -$28.71M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | -$14.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$25.79M 10-Q · filed 2020-08-06 | -$35.64M derived: sum of 3 quarters · filed 2020-08-06 | -$46.25M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$11.73M 10-Q · filed 2020-05-08 | -$21.59M derived: sum of 2 quarters · filed 2020-05-08 | -$32.20M derived: sum of 3 quarters · filed 2020-05-08 | -$43.58M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | -$9.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$20.47M derived: sum of 2 quarters · filed 2020-02-26 | -$31.85M derived: sum of 3 quarters · filed 2020-02-26 | -$40.73M 10-K · filed 2020-02-26 |
| 2018-09-30 | -$10.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$22.00M derived: sum of 2 quarters · filed 2019-10-31 | -$30.87M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | -$11.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$20.26M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | -$8.88M 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | -$11.94M 10-K · filed 2020-02-26 | |||
| 2016-12-31 | -$2.54M 10-K · filed 2019-04-15 |